Description
CYC116 is a potent inhibitor of Aurora A and B with Ki value of 8 nM and 9.2 nM, respectively. It is significantly less potent against a panel of cyclin-dependent kinases and other related kinases, with the exception of Flt-3 (Ki = 44 nM). CYC-116 displays broad-spectrum antiproliferative activity against a panel of human cancer cell lines with a mean IC₅₀ value of 0.54 µM (range = 0.09 – 1.6 µM).
CYC116 is a potent inhibitor of Aurora A and B with Ki value of 8 nM and 9.2 nM, respectively. It is significantly less potent against a panel of cyclin-dependent kinases and other related kinases, with the exception of Flt-3 (Ki = 44 nM). CYC-116 displays broad-spectrum antiproliferative activity against a panel of human cancer cell lines with a mean IC₅₀ value of 0.54 µM (range = 0.09 – 1.6 µM).
Alternate Name/Synonyms: 4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine
Appearance: Crystalline solid
Formulation: N/A
CAS Number: 693228-63-6
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₈H₂₀N₆OS
Molecular Weight: 368.46
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (~ 5 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent inhibitor of Aurora A and B
MDL Number: N/A
PubChem CID: 6420138
SMILES: CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4
InChi: InChI=1S/C18H20N6OS/c1-12-16(26-17(19)21-12)15-6-7-20-18(23-15)22-13-2-4-14(5-3-13)24-8-10-25-11-9-24/h2-7H,8-11H2,1H3,(H2,19,21)(H,20,22,23)
InChi Key: GPSZYOIFQZPWEJ-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |